— Know what they know.
Not Investment Advice

BIOA NASDAQ

BioAge Labs Inc.
1W: -1.6% 1M: -23.8% 3M: -75.3% YTD: -57.4% 1Y: -28.0%
$5.47
+0.48 (+9.62%)
Pre-Market: $5.30 (-0.17, -3.11%)
Weekly Expected Move ±10.0%
$4 $5 $5 $6 $6
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 32 · $205.9M mcap · 32M float · 2.77% daily turnover · Short 44% of daily vol
Credit Risk of going bust: higher than 72% of companies Debt: 1.4% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the third-riskiest tenth, about 1 in 140 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.02 (down 99.7%), BioAge Labs Inc. would be worth roughly what it owes.
Total debt $2.8M against a stock market value of $205.9M.
Distance to default 3.26 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.4M (short-term plus half of long-term), stock volatility 129.6%; Altman Z'' 18.29. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Oct Typical
☁️
Cloudy
+0.0% YTD avg
2026 Now
☁️
Cloudy
Tracking typical
20yr Avg YTD
—
2026 YTD
—
Typical Vol
99%
Annualized
Monthly Weather Forecast
Jan
20yr
💨
+11.4%
50% win 120% vol
Feb
20yr
💨
+9.1%
100% win 49% vol
Mar
20yr
⛈️
-20.1%
0% win 83% vol
Apr
20yr
💨
+4.0%
50% win 63% vol
May
20yr
⛈️
-1.6%
50% win 62% vol
Jun
20yr
💨
+23.0%
100% win 61% vol
Jul
20yr
⛈️
-28.3%
50% win 163% vol
Aug
20yr
💨
+8.6%
100% win 72% vol
Sep
20yr
💨
+2.5%
67% win 69% vol
Oct
20yr
💨
+6.5%
67% win 99% vol
Now: -22.9%
Nov
20yr
💨
+2.5%
50% win 68% vol
Dec
20yr
⛈️
-14.9%
50% win 215% vol

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms